Articles tagged with Bleeding
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers at St. Michael's Hospital found that stroke survivors are more likely to commit driving errors, particularly during complex tasks, and made a greater number of hazardous errors in simulated driving conditions compared to healthy drivers.
Delayed consent to administer tissue plasminogen activator (tPA), a clot-busting drug, occurred in over 50% of cases among ischemic stroke patients. Women and weekends were more likely to experience these delays. Training tools could reduce tPA delay time by improving the consent process. Additionally, insertable cardiac monitoring det...
A study comparing two transfusion strategies for patients with severe trauma found that a balanced ratio of plasma, platelets, and red blood cells resulted in fewer deaths from exsanguination and improved hemostasis within 24 hours. No significant differences were observed in overall mortality at 24 hours or 30 days.
A study of nearly 350 hospitals found that hospital readmissions after surgery are often related to complications from the surgery itself, rather than a worsening of pre-existing medical conditions. The most common reasons for readmission included surgical site infections and intestinal blockages.
A new LA BioMed study found that platelet transfusions and DDAVP are not effective in preventing further bleeding or death in patients with traumatic brain injuries. The researchers analyzed data from 408 patients and found no significant differences in mortality or hemorrhage progression between those who received the treatments and t...
A new interventional radiology procedure has been shown to preserve the uterus in patients with placenta accreta, reducing the risk of massive obstetric hemorrhage and potential hysterectomy. The study found that placement of balloons in the main artery of the pelvis prior to a Caesarean section is safe for both mother and baby.
A new emergency treatment protocol for subarachnoid hemorrhage from ruptured aneurysms significantly reduces in-hospital rebleeding and improves clinical outcomes. Patients treated under the protocol show a lower incidence of repeated hemorrhage within 24 hours, compared to those treated earlier.
The DAPT Study found that continuing dual antiplatelet therapy for at least 30 months significantly reduced the risk of stent thrombosis and major adverse cardiovascular events. This benefit was observed across all stent types and patient characteristics, with a notable reduction in heart attack risk.
A study of 4,524 patients found that intravascular VCDs were more effective than manual compression in achieving hemostasis, with fewer device failures and shorter time to hemostasis. The results suggest that VCDs may be a safer alternative for closing artery access sites following coronary angiography.
Bio-inspired bleeding control is achieved through the synthesis of platelet-like nanoparticles that mimic the human body's own coagulation processes. These tiny particles can be added to blood flow to supply or augment the patient's natural platelet supply, stemming bleeding and initiating healing.
A new screening tool, based on nine clinical variables, helps identify high-risk patients before heart procedures, allowing for strategies to avoid bleeding complications. This led to a significant reduction in post-procedure complications, including the need for blood transfusions, across Allina Health hospitals.
Researchers have developed artificial platelet-like nanoparticles that combine morphological, mechanical, and surface chemical properties of natural platelets. These artificial platelets can simulate natural platelets' ability to collide with red blood cells, enabling selective clot formation at vascular injury sites.
Patients with atrial fibrillation taking dabigatran are at a higher risk of major and gastrointestinal bleeding compared to warfarin users. The study found that African-Americans and patients with chronic kidney disease were more likely to experience major bleeds.
A Medicare beneficiary study suggests dabigatran may be associated with a higher incidence of major bleeding compared to warfarin. Dabigatran was also found to have a higher risk of gastrointestinal bleeding but lower risk of intracranial hemorrhage than warfarin.
A pilot study found that S-equol supplements improved vaginal epithelium and reduced vaginal atrophy in postmenopausal Japanese women. The supplement showed a positive trend to superiority compared to the placebo group without significant abnormalities in vaginal cells or hormone levels.
Combining common painkillers like ibuprofen and aspirin with other medications significantly increases the risk of upper gastrointestinal bleeding. Researchers analyzed data from over 114,000 patients to identify risk factors and recommend strategies to minimize this risk.
A study comparing bioprosthetic and mechanical aortic valve replacements found no significant difference in 15-year survival or stroke rates between the two groups. Bioprosthetic valves were associated with a higher likelihood of reoperation, but lower major bleeding rates.
The Canadian Medical Association Journal refutes criticisms of the BART trial that showed a substantially increased risk of death associated with aprotinin. The authors argue that regulatory bodies should have mandated a second large trial to confirm or refute the results.
A study of 3,481 patients with intracerebral hemorrhage found that inpatient statin use was associated with lower mortality rates and higher discharge rates to home or rehabilitation. The study suggests that continuing statin therapy after brain hemorrhage may be beneficial for improved outcomes.
A GW researcher is investigating the phenomenon of global brain injury in patients with intracerebral hemorrhage (ICH). The study aims to understand the impact of ICH on clinical outcomes and develop more effective treatment strategies. With a grant of $154K, Dr. Shahram Majidi will analyze CT scans and clinical data from 354 patients.
A network meta-analysis of nearly 50 randomized trials compared the efficacy and safety outcomes of eight anticoagulation options for venous thromboembolism. Rivaroxaban and apixaban were associated with the lowest bleeding risk, while UFH-vitamin K antagonist combination was linked to higher recurrent venous thromboembolism rates.
Researchers developed synthetic platelet-like particles that can augment natural blood clotting, potentially reducing trauma-related bleeding deaths. The particles were tested in animal models and human blood, showing effectiveness in slowing bleeding without causing adverse effects.
Researchers found that fibronectin can switch its function from stopping bleeding to preventing overactive blood clots, which could improve results from transfusions.
A study published in Neural Regeneration Research reports on a patient with subarachnoid hemorrhage who showed an unusual neural connection between the injured cingulum and brainstem cholinergic nuclei. The authors used diffusion tensor tractography to investigate this phenomenon.
A study analyzed all trials to date, finding that bivalirudin-based regimens increase the risk of heart attacks and stent thrombosis, while heparin-based regimens decrease bleeding risk. The magnitude of benefit was attenuated when glycoprotein IIb/IIIa inhibitor use was similar in both arms.
A patient with intraventricular hemorrhage (IVH) showed selective verbal memory impairment due to left fornical crus injury, as reported by Dr. Sung Ho Jang and colleagues. The patient's visual memory improved over time, while verbal memory remained impaired.
Anticoagulant-associated intracerebral hemorrhage (AAICH) poses a significant challenge, with a mortality rate as high as 42.3% to 67%. The latest supplement from the Journal of Neurosurgery provides evidence-based guidelines and strategies for managing patients with AAICH.
A study of 90,618 patients with DVT found CDT increased adverse events and hospital charges without significant impact on mortality rates. Patients treated with CDT had more blood transfusions, pulmonary embolism, and vena cava filter placement.
A recent Temple University Health System study compared the safety of two treatments for deep vein thrombosis (DVT): catheter-based clot removal and blood-thinning medication. The study found similar in-hospital mortality rates for both groups, but higher bleeding risks with the catheter procedure.
Researchers have developed nanoparticles that increase survival rates and show no signs of interference in healing after blast trauma. The artificial platelets, called hemostatic nanoparticles, were found to be effective in stopping bleeding and increasing survival rates.
A national team of researchers found that adding clot-busting medications to conventional approaches significantly reduces deaths from sudden-onset pulmonary embolism. The meta-analysis of 16 trials assessed over 2,115 patients and showed a 47% lower mortality rate with thrombolysis.
A meta-analysis of 16 trials found thrombolytic therapy to be associated with a 47% lower odds of death, but also increased risk of major bleeding and intracranial hemorrhage. The study also showed lower rates of recurrent pulmonary embolism in patients treated with thrombolysis.
Researchers at Chalmers University of Technology have developed a new technology that uses microwaves to quickly and accurately diagnose stroke patients. The system, called Strokefinder, has been shown to differentiate between bleeding strokes and clot-induced strokes with great certainty in clinical studies.
A new method developed by Johns Hopkins researchers uses MRI scans to measure damage to the blood-brain barrier, allowing for more precise administration of intravenous tPA. The technique shows promise in predicting which stroke patients will benefit from treatment and which may suffer bleeding complications.
Researchers are exploring a new therapy to eliminate the major risk of minor bleeding after stroke, focusing on diabetic patients who are at higher risk. The treatment involves an iron chelating agent that can remove excess iron from the brain, reducing damage and promoting recovery.
A study published in Neural Regeneration Research found an unusual neural connection between the injured cingulum and brainstem cholinergic nuclei in a patient with subarachnoid hemorrhage. This phenomenon was detected using diffusion tensor tractography, revealing a novel pathway for neural communication.
Researchers found that Hybrid SPECT-CT was 100% accurate in localizing gastrointestinal bleeding in patients with prior surgeries. The technology has the potential to improve clinical care by resolving ambiguities in planar scintigraphy.
A study found that intermittent PPI therapy is non-inferior to continuous infusion, reducing costs and improving patient comfort. Researchers suggest adopting the new approach could lower healthcare costs while maintaining quality care.
Researchers develop software to identify patients at risk of bleeding from stroke treatment, which could help doctors make more accurate assessments and treat more patients. The program uses pattern recognition software similar to airport security to analyze brain scans and predict the likelihood of bleeding with high accuracy.
A quality improvement initiative improved treatment times and reduced complications for over 71,000 stroke patients treated with tissue plasminogen activator (tPA), resulting in lower in-hospital deaths and intracranial hemorrhages.
A specialized ambulance equipped with a CT scanner, laboratory, and telemedicine connection was shown to reduce treatment time for ischemic stroke patients. The study found that the average alarm-to-treatment time decreased by 25 minutes, and the rate of thrombolysis increased from 21% to 33%.
A long-term study of bleeding patterns in women of multiple race/ethnicities during the menopausal transition found that prolonged and heavy bleeding is common, affecting up to 91% of participants. The research provides quantitative data on normal bleeding patterns, which can help alleviate concern and inform diagnostic approaches.
A University of Manchester study reveals that infection after a stroke significantly worsens outcomes, with the immune system's response to the infection causing more damage. Researchers identified specific blood cells and molecules involved in this process, paving the way for potential anti-inflammatory therapies.
Patients given aspirin after non-heart-related surgery had a higher risk of serious bleeding than those who did not receive aspirin. Aspirin did not reduce incidence of post-operative heart attacks and death, according to data from POISE-2.
The AleCardio trial was ended early after patients treated with aleglitazar showed higher rates of heart failure, kidney events, and gastrointestinal bleeding. The study found no cardiovascular benefits despite dual-action on PPAR receptors, leading researchers to consider the class of drug being tested clinically.
A study published in GIE: Gastrointestinal Endoscopy found that cold snare polypectomy significantly reduces the risk of delayed bleeding in patients taking anticoagulants. The procedure outperformed conventional polypectomy in removing small colorectal polyps without causing significant harm to submucosal vessels.
A recent study found that warfarin treatment is associated with a lower risk of death, heart attack, or stroke without an increased risk of bleeding for patients with established cardiovascular disease and atrial fibrillation. The study included over 24,000 patients with kidney function measured through serum creatinine levels.
Researchers aim to create artificial platelets that can stick to injury sites and signal natural platelets to home in on them, offering a potential solution to bleeding disorders. The technology has broad applications in stanching bleeding and detecting diseases.
The Hartford Consensus aims to educate law enforcement on the importance of controlling hemorrhage in active shooter incidents. The initiative, led by the American College of Surgeons, provides training and equipment for police officers to respond to mass casualty events.
Researchers created a synthetic version of low-molecular-weight heparin that can be counteracted by an existing drug and cleared by the liver, not the kidneys. This new form of heparin is safer for patients with poor kidney function, reducing the risk of uncontrolled bleeding.
Researchers found that collecting and bleeding horseshoe crabs for biomedical purposes causes short-term changes in their behavior and physiology. The study suggests delaying the blood harvest or improving transportation conditions could help the animals recover and breed again, potentially mitigating population declines.
Researchers developed an antibody blocking coagulation factor XII, which prevents thrombosis without increasing bleeding risk in clinical settings. This innovation reduces the clotting risk in emergency situations like ECMO treatment and cardiovascular surgery.
A new gene therapy has led to a dramatic decline in bleeding events in dogs with naturally occurring hemophilia A. The treatment involves packaging specialized blood platelets with genes that express clotting factor, resulting in significantly fewer serious bleeding events over three years.
Researchers discover embolic material, polyvinylpyrrolidone (PVP), at site of fatal brain hemorrhages occurring days after aneurysm treatment. PVP is suspected to have traveled through vasculature from PED delivery site to location where hemorrhage occurred.
Scientists will attempt to identify a molecular signal indicating severity of brain-injury in patients at risk for vasospasm after hemorrhagic stroke. The goal is to establish individualized care and respond rapidly to changing health conditions, allowing earlier intervention and preventing secondary injuries.
Synaptosomal-associated protein-25 expression is significantly lower after subarachnoid hemorrhage, which may relate to cognitive disorders that follow. The study found lower expression levels in the temporal lobe, hippocampus, and cerebellum at days 1 and 3.
A study published in the Journal of Clinical Investigation reveals that type 2B von Willebrand disease is associated with platelet dysfunction. Researchers found that a mutation in the von Willebrand factor protein can inhibit platelet activation and promote thrombocytopathy.
The ENGAGE AF-TIMI 48 trial found edoxaban to be at least as effective as warfarin in preventing stroke or systemic embolism, while significantly reducing bleeding and cardiovascular death. High-dose edoxaban showed a 21% reduction in stroke risk and a 20% decrease in major bleeding compared to warfarin.
Researchers at MU School of Medicine found a new protocol using preventive blood thinners reduces life-threatening blood clots in brain-injured patients. The study compared outcomes between 107 and 129 patients treated with or without the medication, showing zero instances of deep-venous clotting among those who received it.
A study of 60 people aged 45 years or older found that accelerated surgery within six hours reduced major complications by 30% compared to standard care. Faster surgery may be better for hip fractures, say researchers at McMaster University.